Liu Y
Zhonghua Yi Xue Za Zhi. 1991 Jul;71(7):362-5, 26.
We prepared monoclonal antibodies (MAbs) against hepatocellular carcinoma using cell suspensions isolated from surgical fresh hepatoma specimens as antigen. Totally we got 6 strains of hybridoma cell lines stably secreting MAbs for more than 2 years. Immunocytochemically they stained positively most of the paraffin embedded hepatoma tissues (63.1 to 91.1%) without reaction to the normal liver tissues. Localization of human hepatoma with 125I or 131I labelled MAbs in nude mice was done by IV injection, which showed clear tumor image by ECT radioimmunodetection and autoradiography of tissues. The T/N ratios of different MAbs were 3.1, 3.6, 5.15 and that of HAb 18-F (ab')2 was 14.4. Among 15 patients suspected to have hepatoma and given the labelled MAb, 13 proved pathologically to be hepatocellular carcinoma.
我们以手术新鲜肝癌标本分离的细胞悬液为抗原,制备了抗肝细胞癌的单克隆抗体(MAb)。我们总共获得了6株稳定分泌单克隆抗体超过2年的杂交瘤细胞系。免疫细胞化学检测显示,它们对大多数石蜡包埋的肝癌组织呈阳性染色(63.1%至91.1%),而对正常肝组织无反应。通过静脉注射,用125I或131I标记的单克隆抗体在裸鼠体内定位人肝癌,通过ECT放射免疫检测和组织放射自显影显示出清晰的肿瘤图像。不同单克隆抗体的T/N比值分别为3.1、3.6、5.15,而HAb 18-F(ab')2的T/N比值为14.4。在15例疑似肝癌并给予标记单克隆抗体的患者中,13例经病理证实为肝细胞癌。